BioAscent Reports Promising Growth as It Marks Tenth AnniversarySteve Jarvis2024-04-15T13:32:06+01:00April 15th, 2024|Accelerator, Investment, News, Wilton Centre|
University of Oxford Spin-Out Named Winner of ‘Golden Ticket’ Programme for Planetary Health InnovationsSteve Jarvis2024-04-12T11:38:38+01:00April 12th, 2024|Accelerator, Investment, News, Wilton Centre|
Cranfield-Colworth Innovation Challenge: A Triumph of Innovation & SustainabilitySteve Jarvis2024-03-26T19:23:11+00:00March 22nd, 2024|Colworth Park, Investment, News|
Scotland’s Thriving Life Sciences Sector Defies PredictionsSteve Jarvis2024-03-21T15:55:33+00:00March 21st, 2024|BioCity Glasgow, Edinburgh Technopole, Investment, News|
Pioneer Group Leads $2.34m Investment in Neobe Therapeutics’ Cancer Therapy InnovationSteve Jarvis2024-02-29T15:29:10+00:00February 29th, 2024|Investment, News|
BioCity Glasgow: BioAscent Invests in New State-of-the-Art Protein Production FacilitySteve Jarvis2024-02-23T15:02:55+00:00February 23rd, 2024|BioCity Glasgow, Investment, News|
IsomAb Closes £7.5m Financing to Drive New Diabetic TreatmentSteve Jarvis2024-03-01T16:00:27+00:00February 21st, 2024|BioCity Nottingham, Investment, News|
MIP Discovery Raises £7m to Advance CommercialisationSteve Jarvis2024-02-21T15:26:40+00:00February 21st, 2024|Colworth Park, Investment, News|
Pioneer Group’s Regeneration Plans for Cambridge’s Grafton Centre ApprovedSteve Jarvis2024-02-23T12:05:19+00:00February 8th, 2024|Article, Headline News, News|
Ireland Accelerator Programme Winners NeuroBell Secure £1.8m Funding RoundSteve Jarvis2024-01-31T12:30:00+00:00January 31st, 2024|Accelerator, News|
